Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Release Earnings on Monday

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) is expected to release its resultson Monday, May 11th. Analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post earnings of $0.15 per share and revenue of $895.5180 million for the quarter.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last announced its quarterly earnings results on Friday, January 30th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.19 by $0.09. The business had revenue of $966.53 million for the quarter, compared to analyst estimates of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.70% and a net margin of 41.82%. On average, analysts expect Shionogi & Co., Ltd. Unsponsored ADR to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

SGIOY stock remained flat at $9.86 during trading on Monday. The company had a trading volume of 10,340 shares, compared to its average volume of 98,851. The firm’s fifty day moving average is $10.74 and its two-hundred day moving average is $9.69. The company has a current ratio of 5.84, a quick ratio of 5.21 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $16.78 billion, a P/E ratio of 12.97, a P/E/G ratio of 0.73 and a beta of 0.10. Shionogi & Co., Ltd. Unsponsored ADR has a twelve month low of $7.38 and a twelve month high of $12.00.

Analyst Upgrades and Downgrades

Several brokerages recently commented on SGIOY. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a research note on Wednesday, April 8th. Zacks Research lowered Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong sell” rating in a research note on Thursday, April 16th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Shionogi & Co., Ltd. Unsponsored ADR presently has an average rating of “Reduce”.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.